No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
761 |
4. Check minimum number of eventsNone |
761 |
5. Include endpointsNone |
761 |
6. Filter based on genotype QC (FinnGen only) |
761 |
Control definitions (FinnGen only)
- Control exclude
- F5_PERSOBEH
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F60
- Name in latin
- Personalitas dependens
Similar endpoints
↥List of similar endpoints to
Dependent personality disorder
based on the number of shared cases.
Similar with more cases:
- Specific personality disorders
- Disorders of adult personality and behaviour
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5983 | 3858 | 2082 |
| Only index persons | 5050 | 3420 | 1630 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.11 | 0.06 |
| Only index persons | 0.11 | 0.13 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 41.52 | 43.53 | 37.69 |
| Only index persons | 41.10 | 43.03 | 37.06 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 761 | 542 | 219 |
| Unadjusted period prevalence (%) | 0.16 | 0.18 | 0.10 |
| Median age at first event (years) | 41.58 | 41.96 | 40.64 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 710
- Matched controls
- 7100
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F60.7
ICD-10 Finland
Dependent personality disorder
16384.0
323.0
557
*
N05AH04
ATC
quetiapine; oral
14.9
204.0
407
588
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
23.8
191.0
288
198
3016A
ICD-9 Finland
Personality disorders, Dependent personality disorder
+∞
174.3
160
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
12.9
159.0
321
426
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
22.8
152.1
229
145
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
17.4
148.3
250
215
N05BA04
ATC
oxazepam; oral
8.6
145.8
431
1083
N05AH03
ATC
olanzapine; systemic
20.9
142.5
221
150
N06AX16
ATC
venlafaxine; oral
9.7
136.2
328
575
N05AA02
ATC
levomepromazine; systemic
27.2
130.7
184
90
F61.0
ICD-10 Finland
Mixed personality disorders
+∞
130.3
121
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
17.9
129.5
213
166
N06AB04
ATC
citalopram; systemic
7.8
129.4
392
970
N06AX11
ATC
mirtazapine; oral
6.8
121.2
461
1519
N05CD07
ATC
temazepam; oral
10.0
117.2
265
398
N05AX08
ATC
risperidone; systemic
15.2
113.3
199
177
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
20.4
112.5
174
111
N06AB06
ATC
sertraline; oral
9.3
108.3
256
407
N05BA01
ATC
diazepam; systemic, rectal
8.3
107.2
277
508
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
10.4
104.7
226
304
N05BE01
ATC
buspirone; oral
29.1
104.2
143
61
N06AB03
ATC
fluoxetine; oral
7.8
100.6
272
526
F34.1
ICD-10 Finland
Dysthymia
21.4
100.5
152
89
T36
ICD-10 Finland
Poisoning by systemic antibiotics
19.0
99.9
158
105
N05AB03
ATC
perphenazine; systemic, rectal
21.3
99.0
150
88
N05AF03
ATC
chlorprothixene; systemic
26.4
96.5
136
63
F60.9
ICD-10 Finland
Personality disorder, unspecified
1053.1
96.3
92
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
517.3
93.6
91
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
+∞
90.6
85
*
N03AG01
ATC
valproic acid; systemic, rectal
14.1
89.6
161
145
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
9.6
89.5
200
278
N05CF01
ATC
zopiclone; oral
5.1
87.8
403
1450
N05BA06
ATC
lorazepam; systemic, sublingual
14.9
84.4
147
122
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
9.0
81.6
189
275
N06AX03
ATC
mianserin; oral
12.3
81.5
156
159
N05BA12
ATC
alprazolam; oral
7.2
79.7
218
409
F41.1
ICD-10 Finland
Generalized anxiety disorder
14.1
78.2
139
120
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
18.8
78.2
123
78
N05AX12
ATC
aripiprazole; systemic
17.2
73.1
119
82
N06AB10
ATC
escitalopram; oral
4.8
69.2
292
901
N06AB05
ATC
paroxetine; oral
9.1
68.3
154
209
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
18.8
64.5
101
62
SPAT1240
SPAT
Therapeutic discussion
6.1
63.9
198
424
N06AA12
ATC
doxepin; systemic
10.1
63.3
133
158
F29
ICD-10 Finland
Unspecified nonorganic psychosis
15.4
61.5
104
78
P76
ICPC
Depressive disorder
8.6
61.2
142
200
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
21.6
61.1
91
48
N03AX09
ATC
lamotrigine; oral
11.8
60.8
117
117
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.6
60.6
174
335
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
48.4
57.9
70
16
P01
ICPC
Feeling anxious/nervous/tense
5.9
57.6
181
389
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
8.6
57.5
133
185
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
21.1
57.4
86
46
N07BB01
ATC
disulfiram; oral
10.6
53.9
109
119
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
44.6
53.0
65
16
N05AN01
ATC
lithium; oral
16.4
52.4
86
59
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
546.0
52.2
51
*
N03AE01
ATC
clonazepam; systemic
7.9
51.9
126
188
N06AG02
ATC
moclobemide; oral
9.4
51.8
112
138
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
16.2
49.2
81
56
N05AC02
ATC
thioridazine; oral
21.8
48.1
71
36
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
11.7
47.2
90
87
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
13.9
46.7
82
66
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
18.4
46.6
73
44
F10.20
ICD-10 Finland
Alcohol dependence currently independent
22.0
46.3
68
34
F60.8
ICD-10 Finland
Other specific personality disorders
476.9
45.8
45
*
C07AA05
ATC
propranolol; systemic
3.7
45.7
249
901
N05AL01
ATC
sulpiride; systemic
22.9
43.5
63
30
N06AA09
ATC
amitriptyline; systemic
5.0
43.4
155
375
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.8
42.8
158
396
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
442.8
42.6
42
*
N05BA02
ATC
chlordiazepoxide; systemic
14.7
42.2
72
54
N04AA02
ATC
biperiden; systemic
19.4
41.9
64
36
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
18.2
41.5
65
39
N05AD01
ATC
haloperidol; systemic
13.2
41.4
74
62
P29
ICPC
Psychological sympt/compl other
6.7
41.0
111
191
N06AX12
ATC
bupropion; oral
6.2
40.5
116
215
N06AA04
ATC
clomipramine; systemic
16.9
40.4
65
42
N05AD03
ATC
melperone; systemic
43.8
39.9
49
12
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
17.2
39.4
63
40
P74
ICPC
Anxiety disorder/anxiety state
9.9
39.1
81
91
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
27.1
38.6
53
21
N06AA06
ATC
trimipramine; systemic
11.1
38.5
75
75
P99
ICPC
Psychological disorders other
13.1
38.5
69
58
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
35.0
38.1
49
15
F31.8
ICD-10 Finland
Other bipolar affective disorders
20.9
37.6
56
29
P03
ICPC
Feeling depressed
4.8
37.6
138
340
F60.5
ICD-10 Finland
Anankastic personality disorder
386.6
37.4
37
*
N06AX05
ATC
trazodone; oral
12.2
36.8
68
61
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
+∞
36.8
35
*
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
26.8
36.3
50
20
N05AA01
ATC
chlorpromazine; systemic, rectal
30.2
36.0
48
17
ZY010
NOMESCO Finland
Hospital outpatient
7.6
35.4
86
126
N05AF01
ATC
flupentixol; systemic
18.4
34.2
53
31
N03AF01
ATC
carbamazepine; oral, rectal
7.1
34.0
87
137
A06AD11
ATC
lactulose; oral
4.1
33.1
145
421
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
34.2
32.6
42
13
P72
ICPC
Schizophrenia
14.0
32.5
56
43
R53
ICD-10 Finland
Malaise and fatigue
3.2
32.2
199
761
N06AX21
ATC
duloxetine; oral
4.0
31.6
141
415
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
63.1
31.4
36
6
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
16.9
30.7
49
31
F41.09
ICD-10 Finland
UNS Panic Syndrome
9.2
30.4
65
77
A10BA02
ATC
metformin; oral
2.9
30.1
236
1051
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
21.2
29.9
44
22
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
6.4
29.4
80
137
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
29.2
326
1779
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
12.4
29.1
53
46
F20.9
ICD-10 Finland
Schizophrenia, unspecified
13.3
29.0
51
41
F32.1
ICD-10 Finland
Moderate depressive episode
5.4
28.4
90
186
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.1
28.4
119
329
F99
ICD-10 Finland
Mental disorder, not otherwise specified
13.8
28.3
49
38
EBA00
NOMESCO Finland
Extraction of tooth
2.5
28.3
298
1570
F40.1
ICD-10 Finland
Social phobias
10.9
28.0
54
53
F41.00
ICD-10 Finland
Moderate panic disorder
16.1
27.2
44
29
N06AB08
ATC
fluvoxamine; oral
7.7
27.0
64
90
F61
ICD-10 Finland
Mixed and other personality disorders
100.7
26.8
29
*
N06AX18
ATC
reboxetine; oral
16.3
26.7
43
28
Z2446
NOMESCO Finland
Social worker
4.9
26.5
92
210
SPAT1307
SPAT
Psychosocial counselling and guidance
5.0
26.1
88
195
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
41.8
26.0
32
8
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
11.4
26.0
49
46
P80
ICPC
Personality disorder
140.1
25.8
27
*
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
17.6
25.6
40
24
AA1AD
NOMESCO Finland
CT of head and brain
2.8
25.6
195
840
N05AF05
ATC
zuclopenthixol; systemic
37.1
25.4
32
9
N05AH02
ATC
clozapine; systemic
12.2
25.3
46
40
30160
ICD-8 Finland
Personality disorders, Asthenic
+∞
25.1
24
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.3
25.0
409
2635
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
22.2
25.0
36
17
N05CD02
ATC
nitrazepam; oral
14.9
24.7
41
29
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.5
24.6
93
232
R42
ICD-10 Finland
Dizziness and giddiness
2.8
24.2
185
795
F10.24
ICD-10 Finland
Alcohol depence active use
13.5
24.2
42
33
N03AX16
ATC
pregabalin; oral
2.6
24.0
224
1081
N05AB01
ATC
dixyrazine; systemic
15.8
24.0
39
26
F10.25
ICD-10 Finland
Alcohol dependence continuous use
15.8
24.0
39
26
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
15.8
24.0
39
26
N05BA05
ATC
potassium clorazepate; oral
20.4
23.7
35
18
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
25.7
23.2
32
13
F39
ICD-10 Finland
Unspecified mood [affective] disorder
15.4
23.2
38
26
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
15.4
23.2
38
26
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
11.1
23.1
44
42
N05CF02
ATC
zolpidem; oral
2.6
23.0
194
882
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
10.8
22.9
44
43
IGY99
NOMESCO Finland
Other psychiatric treatment contact
13.2
22.9
40
32
P15
ICPC
Chronic alcohol abuse
8.6
22.8
50
62
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
3.1
22.8
137
502
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.2
22.8
132
471
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
21.6
22.8
33
16
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.7
22.6
186
829
R06.0
ICD-10 Finland
Dyspnoea
2.5
22.6
213
1027
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
33.5
22.6
29
9
SPAT1249
SPAT
Treatment-related counselling outside office
2.2
22.4
329
1976
SPAT1243
SPAT
Psychiatric/psychological examination
9.6
22.4
46
51
SPAT1234
SPAT
Support of social functional capacity
6.7
22.3
58
93
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
7.2
22.3
55
82
N06AX26
ATC
vortioxetine; oral
4.8
22.2
77
175
F60.0
ICD-10 Finland
Paranoid personality disorder
+∞
22.0
21
*
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
64.6
22.0
25
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
11.4
21.9
41
38
F51.0
ICD-10 Finland
Nonorganic insomnia
3.0
21.8
141
540
C03CA01
ATC
furosemide; systemic
2.6
21.8
192
892
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
13.9
21.7
37
28
IGY02
NOMESCO Finland
Psychiatric monitoring contact
11.1
21.6
41
39
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
27.4
21.5
29
11
N03AX12
ATC
gabapentin; oral
2.8
20.4
150
623
H03AA01
ATC
levothyroxine sodium; systemic
2.4
20.3
224
1163
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.1
20.3
443
3115
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.4
20.2
208
1043
2961E
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
75.7
19.8
22
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.1
19.7
425
2959
103
Kela drug reimbursment
Diabetes, insulin-treated
2.4
19.6
203
1018
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
41.4
19.6
24
6
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.2
19.5
252
1402
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.7
19.5
90
268
SPAT1254
SPAT
Administration of medicine
2.9
19.5
129
499
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
4.0
19.4
82
226
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.4
19.4
197
977
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
47.4
19.3
23
5
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
3.0
19.2
124
472
SPAT1310
SPAT
Counselling related to known health issue
2.2
19.2
258
1464
A28
ICPC
Limited function/disability NOS
3.2
19.1
111
394
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
19.1
119
442
T90
ICPC
Diabetes non-insulin dependent
2.5
19.0
180
861
F33.8
ICD-10 Finland
Other recurrent depressive disorders
16.4
18.9
30
19
SPAT1301
SPAT
No procedures
2.2
18.9
245
1364
SPAT1260
SPAT
Consultation of another employee
2.6
18.8
152
663
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
15.6
18.6
30
20
SAA01
NOMESCO Finland
Simple examination of mouth
2.2
18.5
538
4187
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.1
18.5
60
127
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.1
18.5
74
194
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
8.6
18.4
40
49
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
45.3
18.3
22
5
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
25.8
18.3
25
10
E66.8
ICD-10 Finland
Other obesity
4.2
18.2
71
182
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.2
18.2
250
1423
188
Kela drug reimbursment
Psychosis requiring demanding treatment
15.9
18.1
29
19
F43.1
ICD-10 Finland
Post-traumatic stress disorder
7.4
18.1
43
61
R51.80
ICD-10 Finland
Headache
2.7
18.0
140
597
V03AA01
ATC
NA
9.7
17.8
36
39
L17
ICPC
Foot/toe symptom/complaint
2.3
17.8
207
1091
J45.9
ICD-10 Finland
Asthma, unspecified
2.5
17.6
158
728
3041A
ICD-9 Finland
Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence
184.4
17.6
18
*
30041
ICD-8 Finland
Neuroses, Depressiva
17.5
17.5
27
16
N06AX22
ATC
agomelatine; oral
7.6
17.5
41
57
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.3
17.4
199
1039
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.8
17.4
50
92
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
43.1
17.4
21
5
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
51.3
17.1
20
*
A04
ICPC
Weakness/tiredness general
2.9
16.8
111
426
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
28.3
16.6
22
8
AA400
NOMESCO Finland
Electroconvulsive therapy
23.7
16.5
23
10
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
16.4
146
669
ZY000
NOMESCO Finland
Hospital inpatient
11.5
16.4
30
27
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
16.3
199
1064
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
15.8
16.3
26
17
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.3
16.2
61
151
C07AB07
ATC
bisoprolol; oral
2.0
16.2
313
2025
P20
ICPC
Memory disturbance
3.5
16.1
78
241
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
19.1
16.1
24
13
K59.0
ICD-10 Finland
Constipation
4.7
16.0
55
124
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
16.0
223
1263
F32
ICD-10 Finland
Depressive episode
4.2
15.9
62
159
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
61.4
15.8
18
*
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
16.1
15.8
25
16
F41.01
ICD-10 Finland
Severe panic disorder
34.2
15.8
20
6
KMAK
NOMESCO Finland
NA
1.9
15.6
400
2856
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.1
15.6
90
317
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
10.4
15.6
30
30
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.8
15.3
104
407
F22.0
ICD-10 Finland
Delusional disorder
10.7
15.3
29
28
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.5
15.2
137
630
P06
ICPC
Sleep disturbance
2.8
15.2
102
395
N02BE01
ATC
paracetamol; systemic, rectal
2.4
15.1
620
5290
A01
ICPC
Pain general/multiple sites
3.2
14.9
80
268
N05AE04
ATC
ziprasidone; systemic
32.5
14.9
19
6
N06AX17
ATC
milnacipran; oral
10.0
14.8
29
30
SPAT1312
SPAT
General health counselling
2.0
14.7
247
1500
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
4.2
14.7
56
141
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
14.6
218
1259
N05AC01
ATC
periciazine; systemic
81.8
14.6
16
*
3090A
ICD-9 Finland
Adjustment reaction, Brief depressive reaction
36.9
14.5
18
5
WX110
NOMESCO Finland
Local anesthesy
1.9
14.4
511
4046
R05
ICPC
Cough
2.2
14.4
181
974
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
27.8
14.3
19
7
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
14.3
218
1272
A02BC02
ATC
pantoprazole; systemic
1.9
14.2
473
3646
G04BD04
ATC
oxybutynin; oral, transdermal
4.2
14.2
55
140
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.6
14.1
113
487
F41.3
ICD-10 Finland
Other mixed anxiety disorders
11.2
14.1
26
24
A02BC03
ATC
lansoprazole; oral
2.0
14.0
231
1385
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.4
14.0
136
647
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
30.7
13.9
18
6
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
30.7
13.9
18
6
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
20.5
13.8
20
10
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.9
13.8
45
97
K02.1
ICD-10 Finland
Caries of dentine
1.8
13.7
425
3179
A02BA04
ATC
nizatidine; systemic
3.3
13.7
71
232
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
13.6
201
1154
F10.09
ICD-10 Finland
Alcohol intoxication UNS
6.7
13.5
34
53
F41.8
ICD-10 Finland
Other specified anxiety disorders
5.8
13.5
38
69
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.8
13.4
92
360
A03FA02
ATC
cisapride; oral, rectal
3.1
13.4
75
257
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
21.6
13.4
19
9
D12
ICPC
Constipation
5.4
13.4
40
78
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
13.3
69
225
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
10.0
13.3
26
27
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
14.1
13.3
22
16
P28
ICPC
Limited function/disability (P)
12.5
13.2
23
19
M79.6
ICD-10 Finland
Pain in limb
1.9
13.2
272
1767
N03AF02
ATC
oxcarbazepine; oral
5.2
13.1
40
80
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.6
13.1
33
52
S06.0
ICD-10 Finland
Concussion
2.7
13.0
91
362
F21
ICD-10 Finland
Schizotypal disorder
29.0
13.0
17
6
K59.09
ICD-10 Finland
Constipation, unspecified
3.8
13.0
56
158
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
19.5
13.0
19
10
Z72.8
ICD-10 Finland
Other problems related to lifestyle
23.0
12.9
18
8
30180
ICD-8 Finland
Personality disorders, Immatura
23.0
12.9
18
8
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
23.0
12.9
18
8
J01DA01
ATC
[U] cefalexin; systemic
1.8
12.9
462
3592
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.0
12.8
78
284
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.7
310
2120
R02
ICPC
Shortness of breath/dyspnoea
2.6
12.7
101
432
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
12.6
12.7
22
18
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.0
12.6
77
281
Z63.0
ICD-10 Finland
Problems in relationship with spouse or partner
11.3
12.6
23
21
A02BA02
ATC
ranitidine; systemic
2.1
12.5
159
852
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
24.8
12.5
17
7
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
20.5
12.5
18
9
F90.0
ICD-10 Finland
Disturbance of activity and attention
8.2
12.4
27
34
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
11.9
12.4
22
19
P16
ICPC
Acute alcohol abuse
9.2
12.3
25
28
SPAT1262
SPAT
Handing over of treatment supplies
2.2
12.3
136
685
Z2445
NOMESCO Finland
Psychologist
4.2
12.3
46
114
WX290
NOMESCO Finland
Other blockade of nerve
1.8
12.3
338
2399
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
38.3
12.2
15
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.4
12.2
114
531
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
12.1
60
189
B18.2
ICD-10 Finland
Chronic viral hepatitis C
11.3
12.1
22
20
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
18.4
12.1
18
10
T82
ICPC
Obesity
3.9
12.0
49
132
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.8
12.0
431
3315
L28
ICPC
Limited function/disability (L)
2.3
11.9
112
524
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.9
11.8
38
81
A02BC01
ATC
omeprazole; systemic
1.9
11.8
196
1166
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.0
11.8
191
1125
-1
NOMESCO Finland
NA
1.8
11.7
254
1659
ZYC01
NOMESCO Finland
Remote contact by phone
3.8
11.7
50
140
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
5.4
11.6
34
65
F20.5
ICD-10 Finland
Residual schizophrenia
23.3
11.6
16
7
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
23.3
11.6
16
7
S22.3
ICD-10 Finland
Fracture of rib
3.4
11.6
57
179
C10AA01
ATC
simvastatin; oral
1.8
11.6
265
1761
SPAT1053
SPAT
Memory test
2.7
11.6
83
335
SPAT1216
SPAT
Assessment of functional ability
2.4
11.6
107
494
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
11.5
97
428
F60.1
ICD-10 Finland
Schizoid personality disorder
+∞
11.5
11
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.6
11.5
51
148
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
121.9
11.5
12
*
2918A
ICD-9 Finland
Alcoholic psychoses, Other specified alcoholic psychosis
121.9
11.5
12
*
L03
ICPC
Low back symptom/complaint
1.9
11.4
182
1068
H13
ICPC
Plugged feeling ear
2.3
11.4
119
583
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
15.3
11.4
18
12
Z71.8
ICD-10 Finland
Other specified counselling
1.9
11.3
183
1077
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
35.6
11.3
14
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
35.6
11.3
14
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.8
11.3
31
55
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
17.4
11.2
17
10
F32.8
ICD-10 Finland
Other depressive episodes
7.8
11.2
25
33
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
11.2
144
772
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.9
11.2
45
120
R33
ICD-10 Finland
Retention of urine
3.6
11.2
50
146
M54.5
ICD-10 Finland
Low back pain
1.8
11.1
248
1631
W19
ICD-10 Finland
Unspecified fall
2.7
11.1
77
305
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.1
11.1
62
212
L16
ICPC
Ankle symptom/complaint
2.6
11.0
82
338
SPAT1058
SPAT
PEF monitoring instruction
2.8
11.0
73
282
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.7
11.0
76
301
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
15.8
10.9
17
11
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
10.8
138
739
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
9.8
10.8
21
22
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.7
10.8
309
2189
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.1
10.8
58
195
E66.00
ICD-10 Finland
Metabolic syndrome
3.1
10.8
58
195
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.8
10.8
45
124
E66.01
ICD-10 Finland
Obesity due to excess calories
2.6
10.8
80
328
A29
ICPC
General symptom/complaint other
2.5
10.8
89
388
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
28.5
10.8
14
5
P18
ICPC
Medication abuse
21.8
10.7
15
7
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.2
10.7
56
185
WZA90
NOMESCO Finland
Other doctors statement
1.9
10.7
175
1033
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.6
10.6
47
136
SPAT1263
SPAT
Sampling
1.7
10.6
306
2169
-
ICD-10 Finland
NA
5.2
10.6
32
64
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.6
10.5
80
335
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
7.0
10.5
25
37
R03AC02
ATC
salbutamol; inhalant
1.7
10.4
378
2856
R07.3
ICD-10 Finland
Other chest pain
2.7
10.4
75
302
M79.1
ICD-10 Finland
Myalgia
2.2
10.4
111
549
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
10.4
131
696
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
16.3
10.4
16
10
G44.2
ICD-10 Finland
Tension-type headache
2.2
10.4
117
594
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.0
10.3
158
908
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
9.0
10.3
21
24
R96
ICPC
Asthma
2.6
10.3
78
324
F45.0
ICD-10 Finland
Somatization disorder
19.1
10.3
15
8
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
23.8
10.3
14
6
R11
ICD-10 Finland
Nausea and vomiting
2.8
10.2
67
256
N02AA05
ATC
oxycodone; systemic
2.3
10.2
101
483
SPAT1235
SPAT
Mental health, emotional support
13.4
10.2
17
13
SPAT1251
SPAT
Organisation of medication
4.2
10.2
38
95
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
10.1
94
436
R52.2
ICD-10 Finland
Other chronic pain
4.5
10.1
35
81
L02
ICPC
Back symptom/complaint
2.5
10.1
80
341
G47.3
ICD-10 Finland
Sleep apnoea
1.9
10.1
164
959
R55
ICD-10 Finland
Syncope and collapse
2.6
10.1
76
314
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.8
10.1
201
1268
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
10.0
162
947
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.9
10.0
27
47
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.0
10.0
58
205
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
10.0
100
481
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
40.7
10.0
12
*
ZXD05
NOMESCO Finland
Urgent procedure
1.8
10.0
216
1396
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
10.0
298
2122
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
9.9
133
724
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.4
9.9
86
384
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.8
9.9
63
238
3092E
ICD-9 Finland
Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]
26.4
9.8
13
5
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
26.4
9.8
13
5
D01AC02
ATC
miconazole; topical
2.7
9.8
66
257
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
10.8
9.8
18
17
F31
ICD-10 Finland
Bipolar affective disorder
9.7
9.8
19
20
UJF32
NOMESCO Finland
Coloscopy
1.8
9.8
179
1095
F33
ICD-10 Finland
Recurrent depressive disorder
5.5
9.8
28
53
R05FB02
ATC
cough suppressants and expectorants
1.7
9.7
273
1908
U04
ICPC
Incontinence urine
3.9
9.7
39
105
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.5
9.6
76
323
R03BB04
ATC
tiotropium bromide; inhalant
2.6
9.6
70
285
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
10.2
9.6
18
18
S18
ICPC
Laceration/cut
1.7
9.6
281
1988
Z00.0
ICD-10 Finland
General medical examination
2.0
9.5
134
741
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
2.1
9.5
107
542
2961A
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]
101.3
9.4
10
*
30088
ICD-8 Finland
Neuroses, Other
101.3
9.4
10
*
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
101.3
9.4
10
*
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
17.8
9.4
14
8
R60.0
ICD-10 Finland
Localized oedema
2.4
9.4
79
349
T43.0
ICD-10 Finland
Poisoning: Tricyclic and tetracyclic antidepressants
+∞
9.4
9
*
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
9.4
9
*
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
12.6
9.4
16
13
IER01
NOMESCO Finland
Psychoeducation, group
22.0
9.4
13
6
S01.0
ICD-10 Finland
Open wound of scalp
2.8
9.4
59
221
E000001
ATC
NA
1.9
9.3
152
891
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
10.9
9.3
17
16
D07AA02
ATC
hydrocortisone; topical
2.1
9.3
108
554
F03
ICD-10 Finland
Unspecified dementia
6.2
9.3
24
40
L12
ICPC
Hand/finger symptom/complaint
2.1
9.3
106
541
G04BD12
ATC
mirabegron; oral
2.6
9.3
68
276
R52.9
ICD-10 Finland
Pain, unspecified
2.5
9.2
72
305
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
13.9
9.2
15
11
R06.4
ICD-10 Finland
Hyperventilation
6.8
9.2
22
33
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
9.2
135
760
K92.1
ICD-10 Finland
Melaena
3.7
9.2
39
110
F43.29
ICD-10 Finland
Adaptation disorder UNS
4.8
9.1
29
62
T74.1
ICD-10 Finland
Physical abuse
6.0
9.1
24
41
OAB43
SPAT
NA
0.4
9.1
30
775
S22
ICPC
Nail symptom/complaint
3.1
9.1
51
175
N01
ICPC
Headache
2.4
9.1
81
366
P98
ICPC
Psychosis NOS/other
15.8
9.1
14
9
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
15.8
9.1
14
9
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
37.2
9.0
11
*
U05
ICPC
Urination problems other
3.6
9.0
39
112
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.7
9.0
38
107
SPAT1252
SPAT
Overall medication plan or its review
2.9
9.0
53
191
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.1
9.0
48
162
K10.3
ICD-10 Finland
Alveolitis of jaws
3.1
9.0
48
162
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.6
8.9
30
68
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
24.4
8.9
12
5
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
24.4
8.9
12
5
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
24.4
8.9
12
5
D11
ICPC
Diarrhoea
2.2
8.9
88
420
K08.3
ICD-10 Finland
Retained dental root
2.9
8.9
53
192
C07AB02
ATC
metoprolol; systemic
2.0
8.9
124
684
N05CD08
ATC
midazolam; nasal, systemic
5.1
8.9
27
55
L01
ICPC
Neck symptom/complaint
2.1
8.8
109
574
N17
ICPC
Vertigo/dizziness
2.4
8.8
77
344
H29
ICPC
Ear symptom/complaint other
2.4
8.8
75
333
A02BC05
ATC
esomeprazole; systemic
1.6
8.8
291
2109
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
8.8
144
842
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
8.8
237
1626
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.2
8.8
44
142
N05BB01
ATC
hydroxyzine; systemic
2.7
8.7
58
223
R63.1
ICD-10 Finland
Polydipsia
50.6
8.7
10
*
N05AA03
ATC
promazine; systemic
50.6
8.7
10
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
8.7
135
778
R41.0
ICD-10 Finland
Disorientation, unspecified
4.9
8.6
27
57
D01
ICPC
Abdominal pain/cramps general
2.3
8.6
85
404
A03CA02
ATC
clidinium and psycholeptics; oral
2.9
8.6
51
185
N03AX11
ATC
topiramate; oral
4.1
8.5
32
81
IEV99
NOMESCO Finland
Other psychiatric network intervention
27.9
8.5
11
*
P01AB01
ATC
metronidazole; oral, rectal
1.6
8.5
300
2209
I95.1
ICD-10 Finland
Orthostatic hypotension
5.8
8.5
23
41
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
8.5
133
765
A10BH01
ATC
sitagliptin; oral
2.4
8.4
72
319
EBA30
NOMESCO Finland
Excision of root of tooth
3.2
8.4
42
135
M25.5
ICD-10 Finland
Pain in joint
1.7
8.4
212
1422
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
13.0
8.4
14
11
Z00.8
ICD-10 Finland
Other general examinations
2.6
8.4
61
250
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
8.4
61
250
F20.6
ICD-10 Finland
Simple schizophrenia
+∞
8.3
8
*
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.3
8.3
40
125
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
10.9
8.3
15
14
G40
ICD-10 Finland
Epilepsy
9.6
8.3
16
17
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.7
8.3
34
94
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
8.2
83
399
N05AB02
ATC
fluphenazine; systemic
14.7
8.2
13
9
S29
ICPC
Skin symptom/complaint other
2.0
8.2
117
650
A01AB09
ATC
miconazole; local oral
2.4
8.2
71
318
Z3231
NOMESCO Finland
Registered nurse
1.7
8.2
188
1225
K92.0
ICD-10 Finland
Haematemesis
4.8
8.2
26
56
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
8.2
347
2669
J01EA01
ATC
trimethoprim; systemic
1.7
8.1
183
1184
S21
ICPC
Skin texture symptom/complaint
2.1
8.1
95
486
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
6.9
8.1
19
28
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.3
8.1
40
128
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
8.1
99
517
Z02.7
ICD-10 Finland
Issue of medical certificate
2.9
8.1
48
174
N06AC02
ATC
NA
33.8
8.1
10
*
97010
ICD-8 Finland
Adverse effect of psychotherapeutics, Tranquillisers
17.4
8.1
12
7
Z72.2
ICD-10 Finland
Drug use
17.4
8.1
12
7
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
5.1
8.1
24
48
S10
ICPC
Boil/carbuncle
2.9
8.1
47
168
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.4
8.1
20
32
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.8
8.0
33
91
F34.0
ICD-10 Finland
Cyclothymia
22.3
8.0
11
5
E0000UV
ATC
NA
1.6
8.0
265
1911
F05.9
ICD-10 Finland
Delirium, unspecified
6.7
7.9
19
29
RS220
NOMESCO Finland
NA
6.7
7.9
19
29
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.8
7.9
48
177
A11
ICPC
Chest pain NOS
2.6
7.9
57
231
E66.9
ICD-10 Finland
Obesity, unspecified
3.4
7.9
37
114
XKD00
NOMESCO Finland
Uroflowmetry
2.2
7.9
81
394
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
11.0
7.8
14
13
R4140
NOMESCO Finland
Psychotherapy
11.0
7.8
14
13
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
7.8
82
402
R21
ICPC
Throat symptom/complaint
1.8
7.7
147
903
Z29
ICPC
Social problem NOS
5.4
7.7
22
42
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
7.7
106
579
Z11
ICPC
Compliance/being ill problem
15.2
7.7
12
8
ZXY60
NOMESCO Finland
2-person team, nurses
15.2
7.7
12
8
RS221
NOMESCO Finland
NA
6.0
7.7
20
34
X84
ICD-10 Finland
Intentional self-harm by unspecified means
45.5
7.7
9
*
79020
ICD-8 Finland
Nervousness and debility, Depression
45.5
7.7
9
*
G47.9
ICD-10 Finland
Sleep disorder, unspecified
4.8
7.7
24
51
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.1
7.7
90
463
N05CD05
ATC
triazolam; oral, sublingual
8.2
7.6
16
20
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
18.6
7.6
11
6
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
18.6
7.6
11
6
ZYD01
NOMESCO Finland
Emergency clinic
18.6
7.6
11
6
SPAT1229
SPAT
Assessment of need for aid
2.5
7.6
56
231
RT250
NOMESCO Finland
NA
25.3
7.6
10
*
X15
ICPC
Vaginal symptom/complaint other
3.6
7.6
32
91
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
7.6
93
486
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
80.9
7.4
8
*
N76.0
ICD-10 Finland
Acute vaginitis
2.6
7.4
52
209
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
7.4
449
3723
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
7.8
7.4
16
21
S01
ICPC
Pain/tenderness of skin
3.2
7.4
37
120
IGY02
SPAT
NA
13.5
7.4
12
9
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.8
7.3
29
78
Z3226
NOMESCO Finland
Physiotherapist
1.8
7.3
134
812
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
7.3
268
1970
F20.0
ICD-10 Finland
Paranoid schizophrenia
11.0
7.3
13
12
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.7
7.3
154
976
SPAT1285
SPAT
Provision of consultation response
2.8
7.3
46
172
Z08
ICPC
Social welfare problem
6.3
7.3
18
29
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
15.9
7.2
11
7
R06AE07
ATC
cetirizine; oral
1.5
7.2
310
2367
S02
ICPC
Pruritus
3.6
7.2
30
85
SPAT1246
SPAT
Screening of depression or other psychiatric problem
3.1
7.2
38
129
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
20.3
7.1
10
5
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
20.3
7.1
10
5
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
4.6
7.1
23
51
EBA10
NOMESCO Finland
Surgical removal of tooth
2.0
7.1
86
448
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
12.2
7.1
12
10
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.2
7.1
73
354
C09AA05
ATC
ramipril; oral
1.8
7.1
135
831
R25.1
ICD-10 Finland
Tremor, unspecified
3.7
7.0
29
81
R35
ICD-10 Finland
Polyuria
2.7
7.0
46
179
N04BC05
ATC
pramipexole; oral
2.4
7.0
60
267
G04BD09
ATC
trospium; oral
4.7
6.9
22
48
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
4.7
6.9
22
48
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
6.9
65
303
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
7.6
6.9
15
20
F40.2
ICD-10 Finland
Specific (isolated) phobias
7.6
6.9
15
20
3000B
ICD-9 Finland
Neurotic disorders, Anxiety states[PANIIKKIHÄIRIÖ]
13.9
6.9
11
8
K59.1
ICD-10 Finland
Functional diarrhoea
2.8
6.9
41
150
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
4.9
6.9
21
44
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
6.8
57
252
IEY01
NOMESCO Finland
Psychoeducation, individual
11.1
6.8
12
11
E86
ICD-10 Finland
Volume depletion
5.4
6.8
19
36
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
9.4
6.8
13
14
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.8
6.8
21
45
G04BD01
ATC
emepronium; systemic
16.9
6.8
10
6
ZXY49
NOMESCO Finland
Other health care provider
16.9
6.8
10
6
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
7.3
6.7
15
21
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
6.7
51
215
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
22.8
6.7
9
*
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
22.8
6.7
9
*
F29
ICPC
Eye symptom/complaint other
2.3
6.7
59
269
N06BA04
ATC
methylphenidate; oral
5.6
6.6
18
33
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.1
6.6
24
60
SFA00
NOMESCO Finland
Small filling
1.9
6.6
96
538
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
12.4
6.6
11
9
X78
ICD-10 Finland
Intentional self-harm by sharp object
12.4
6.6
11
9
IGV01
NOMESCO Finland
Psychiatric network contact
12.4
6.6
11
9
F50.2
ICD-10 Finland
Bulimia nervosa
8.8
6.6
13
15
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
6.6
266
1993
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
10.1
6.5
12
12
IHZ05
SPAT
NA
5.1
6.5
19
38
G04CA02
ATC
tamsulosin; oral
1.9
6.5
93
515
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
4.6
6.5
21
47
H02
ICPC
Hearing complaint
2.1
6.5
69
341
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
70.5
6.4
7
*
P27
ICPC
Fear of mental disorder
7.5
6.4
14
19
M02AA07
ATC
piroxicam; topical
1.5
6.4
255
1897
Z01
ICPC
Poverty/financial problem
14.5
6.4
10
7
29580
ICD-8 Finland
Schizophrenia, Other
14.5
6.4
10
7
F30.9
ICD-10 Finland
Manic episode, unspecified
14.5
6.4
10
7
F45.8
ICD-10 Finland
Other somatoform disorders
2.3
6.4
56
252
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.9
6.4
92
513
C05AA08
ATC
fluocortolone; rectal, topical
1.9
6.4
99
566
M79.7
ICD-10 Finland
Fibromyalgia
3.0
6.3
34
117
F43.00
ICD-10 Finland
Acute stress reaction mild
3.7
6.3
26
73
N30.0
ICD-10 Finland
Acute cystitis
1.9
6.3
97
551
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
11.1
6.3
11
10
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
11.1
6.3
11
10
J45.1
ICD-10 Finland
Nonallergic asthma
2.4
6.3
51
223
N05AE03
ATC
sertindole; oral
18.2
6.3
9
5
N05AE05
ATC
lurasidone; oral
18.2
6.3
9
5
M70.6
ICD-10 Finland
Trochanteric bursitis
1.9
6.3
91
507
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.5
6.3
48
204
T42.7
ICD-10 Finland
Poisoning: Antiepileptic and sedative-hypnotic drugs, unspecified
+∞
6.3
6
*
F60.4
ICD-10 Finland
Histrionic personality disorder
+∞
6.3
6
*
E970A
ICD-9 Finland
Injury due to legal intervention by firearms
+∞
6.3
6
*
F69
ICD-10 Finland
Unspecified disorder of adult personality and behaviour
+∞
6.3
6
*
R03BA01
ATC
beclometasone; inhalant
1.9
6.2
95
541
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.5
6.2
47
196
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
26.9
6.2
8
*
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
26.9
6.2
8
*
Z91.5
ICD-10 Finland
Personal history of self-harm
26.9
6.2
8
*
J01FF01
ATC
clindamycin; systemic
1.6
6.2
190
1325
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
6.2
58
270
J46
ICD-10 Finland
Status asthmaticus
3.8
6.2
24
64
R51
ICD-10 Finland
Headache
2.6
6.2
43
171
D09
ICPC
Nausea
2.9
6.2
35
123
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.7
6.1
19
41
F20
ICD-10 Finland
Schizophrenia
8.7
6.1
12
14
H92.0
ICD-10 Finland
Otalgia
2.5
6.1
46
193
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.1
6.1
64
316
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
6.1
54
245
SPAT1210
SPAT
Application of cast or individual aid
2.8
6.0
37
139
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.3
6.0
54
246
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.9
6.0
88
495
E000006
ATC
NA
2.3
6.0
52
235
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009466) Valproate [Moles/volume] in Serum or Plasma
76
75
11.15
68.96
6.3
5.7
umol/l
362.2
369.1
0.13
68
67
(3028707) Methadone [Presence] in Urine by Screen method
68
77
9.60
55.71
4.7
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
202
778
3.17
39.59
2.4
1.7
%
1.5
1.5
0.71
183
690
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
367
1980
2.65
37.70
3.5
2.5
u/l
49.4
56.5
4.60
341
1824
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
40
38
11.05
36.92
20.5
21.5
nmol/l
1375.3
1553.9
0.53
40
38
(3019309) Folate [Moles/volume] in Red Blood Cells
221
950
2.87
35.13
1.9
1.6
nmol/l
1228.4
1212.4
0.10
181
725
(3011288) Drugs identified in Urine by Screen method
69
132
5.65
34.99
5.6
1.6
—
—
—
0
0
(4198724)
31
22
14.65
34.10
2.3
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
497
3234
2.55
32.62
6.6
6.1
umol/l
8.7
10.8
8.07
469
3069
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
280
1406
2.57
32.27
2.4
2.0
mg/l
3.0
3.0
0.10
250
1213
(1001926) Buprenorphine [Presence] in Urine by Screen method
73
159
4.97
31.96
4.5
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
462
2927
2.47
31.83
8.6
6.3
mmol/l
1.2
1.2
0.37
392
2478
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
365
2125
2.38
29.82
4.8
3.2
u/l
28.0
30.6
1.71
353
2037
(3016879) Cocaine [Presence] in Urine
76
191
4.31
27.82
4.5
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
385
2347
2.30
27.60
2.4
1.8
pmol/l
93.9
96.3
0.49
198
1178
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
418
2644
2.29
27.34
7.5
5.5
mmol/l
1.2
1.2
0.54
386
2409
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
639
4879
2.93
27.31
9.4
7.3
u/l
79.9
77.6
0.67
611
4594
(3000764) Benzodiazepines [Presence] in Urine
78
204
4.15
27.08
4.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
77
205
4.07
26.08
4.5
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
77
207
4.03
25.73
4.5
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
235
1206
2.37
24.71
1.9
1.6
pmol/l
38614305.2
42296803.3
0.03
202
1019
(3027944) Amphetamines [Presence] in Urine
75
204
3.97
24.64
4.5
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
502
3527
2.24
24.11
6.9
4.5
mmol/l
6.7
6.6
0.62
467
3291
(3024561) Albumin [Mass/volume] in Serum or Plasma
390
2492
2.16
23.71
5.9
4.5
g/l
35.8
36.0
0.27
360
2331
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
304
1784
2.17
22.77
2.9
2.1
u/l
281.6
153.8
1.03
282
1692
(3009508) Creatinine [Moles/volume] in Urine
315
1875
2.16
22.74
3.8
3.1
mmol/l
6.8
7.5
1.81
269
1601
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
355
2235
2.10
21.91
4.5
3.3
ng/l
20.6
34.2
2.50
255
1434
(3026008) Bacteria identified in Urine by Culture
299
1766
2.14
21.82
4.2
2.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
237
1286
2.22
21.36
1.6
1.5
nmol/l
20.0
21.8
1.03
214
1108
(3018418) pH of Serum or Plasma
294
1754
2.10
20.64
4.7
3.8
ph
7.4
7.4
0.83
67
337
(3023368) Bacteria identified in Blood by Culture
260
1484
2.14
20.47
4.7
3.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
241
1342
2.16
20.17
5.2
3.6
kg/l
1.0
1.0
0.02
30
192
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
637
5114
2.51
19.94
6.1
4.1
pmol/l
14.4
14.7
2.41
602
4708
(3015377) Calcium [Moles/volume] in Serum or Plasma
325
2035
2.04
19.82
3.2
3.3
mmol/l
2.4
2.4
0.20
291
1809
(3031040) Bacteria [#/volume] in Urine by Automated count
548
4143
2.15
19.74
6.6
3.9
e6/l
54.3
799.3
—
10
54
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
101
391
2.83
18.71
2.1
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
442
3141
1.97
18.24
7.1
5.8
e9/l
0.0
0.0
0.31
391
2731
(3026782) Osmolality of Urine
205
1109
2.16
18.21
3.1
2.6
mosm/kgh2o
493.4
539.0
1.95
181
951
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
21
22
9.79
17.96
2.3
1.8
umol/l
171.2
55.1
—
10
14
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
172
872
2.26
17.92
2.0
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
114
480
2.62
17.90
4.9
3.3
mmol/l
2.3
2.0
0.45
99
384
(3001604) Monocytes [#/volume] in Blood
439
3129
1.95
17.77
7.1
5.8
e9/l
0.6
0.6
0.91
388
2722
(3007853) Bacteria identified in Skin by Aerobe culture
146
696
2.36
17.54
1.8
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
493
3665
1.98
17.50
13.5
9.0
e9/l
4.3
4.0
1.87
439
3230
(3019198) Lymphocytes [#/volume] in Blood
447
3215
1.95
17.50
7.2
5.8
e9/l
2.0
1.9
1.19
395
2852
(3013115) Eosinophils [#/volume] in Blood
448
3255
1.92
16.67
8.2
6.1
e9/l
0.2
0.2
0.18
401
2887
(3000850) Epithelial cells [#/volume] in Urine
214
1216
2.06
16.48
2.9
2.4
e6/l
7.7
6.4
0.47
187
1081
(3020191) Ethanol [Moles/volume] in Serum or Plasma
26
40
6.69
16.29
2.9
1.5
promille
1.6
1.2
0.47
17
32
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
131
615
2.37
16.22
1.9
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
130
609
2.37
16.17
1.8
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
15
11
13.89
15.95
1.8
2.0
umol/l
22.5
17.2
0.54
15
11
(3003458) Phosphate [Moles/volume] in Serum or Plasma
147
730
2.26
15.94
6.0
5.2
mmol/l
1.1
1.0
0.28
132
677
(3020682) Albumin/Creatinine [Ratio] in Urine
288
1839
1.91
15.69
4.1
3.9
mg/mmol
8.1
7.7
0.05
184
1128
(3018095) Leukocytes [#/volume] in Urine
320
2133
1.86
15.12
4.5
3.4
e6/l
27.9
94.3
2.20
250
1473
(3012516) Albumin [Mass/volume] in Urine
275
1749
1.90
15.03
3.4
3.2
mg/l
1247.5
245.4
1.16
174
1072
(3037467) Urinalysis macro (dipstick) panel - Urine
550
4349
1.95
15.03
5.4
4.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
696
6032
2.80
15.00
7.4
4.7
mu/l
1.9
2.1
0.41
662
5567
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
247
1522
1.92
14.83
2.9
2.9
ng/l
1178.5
876.2
0.44
205
1270
(3003181) Sodium [Moles/volume] in Urine
36
83
4.50
14.65
2.0
1.3
mmol/l
51.8
61.8
1.03
26
72
(3014111) Lactate [Moles/volume] in Serum or Plasma
109
496
2.40
14.40
7.1
6.5
mmol/l
1.3
1.3
0.07
101
481
(42870588) Differential panel, method unspecified - Blood
308
2057
1.84
14.25
6.4
5.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
273
1772
1.84
13.74
3.8
3.0
e6/l
27.6
65.7
1.47
235
1348
(3014576) Chloride [Moles/volume] in Serum or Plasma
136
694
2.17
13.66
7.4
6.6
mmol/l
102.7
104.1
1.59
129
676
(3022948) Iron [Moles/volume] in Serum or Plasma
159
864
2.06
13.54
3.0
2.3
umol/l
12.9
13.4
0.29
148
803
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
183
1047
1.98
13.50
3.1
2.8
mmol/l
2.4
2.4
0.04
156
928
(3012095) Magnesium [Moles/volume] in Serum or Plasma
168
941
2.01
13.12
3.1
3.3
mmol/l
0.8
0.8
0.13
155
887
(3035350) Ketones [Presence] in Urine by Test strip
418
3131
1.74
12.54
5.0
3.4
estimate
0.0
0.0
0.00
79
589
(3003396) Base excess in Arterial blood by calculation
122
617
2.16
12.47
8.8
7.7
mmol/l
1.9
1.1
1.03
98
506
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
79
332
2.54
12.34
1.8
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
578
4769
1.88
12.33
4.4
4.0
mm/h
12.9
11.3
1.86
546
4437
(3030467) Casts [#/volume] in Urine by Automated count
250
1625
1.80
12.25
3.6
2.9
e6/l
0.2
0.4
1.18
210
1206
(40758558) Short blood count panel - Blood
248
1609
1.80
12.22
7.5
6.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
422
3190
1.72
12.06
5.1
3.4
estimate
0.0
0.0
0.80
81
571
(3019060) Gas panel - Arterial blood
80
344
2.48
11.91
6.6
5.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
144
790
2.01
11.83
3.0
2.3
g/l
2.5
2.4
1.48
128
739
(3006504) Eosinophils/100 leukocytes in Blood
393
2935
1.70
11.56
7.5
5.9
%
2.6
2.9
2.05
370
2733
(3020779) Urea [Moles/volume] in Serum or Plasma
96
455
2.27
11.47
7.5
7.3
mmol/l
7.9
8.6
0.49
86
440
(3021601) Nitrite [Presence] in Urine by Test strip
416
3160
1.70
11.43
6.1
4.6
estimate
0.0
0.0
0.50
79
597
(3029937) Albumin [Presence] in Urine by Test strip
254
1687
1.76
11.41
6.0
3.7
estimate
0.0
0.0
0.88
79
585
(3022096) Basophils/100 leukocytes in Blood
381
2829
1.69
11.39
7.3
5.9
%
0.6
0.7
2.47
360
2640
(3018405) Lactate [Moles/volume] in Arterial blood
54
195
2.90
11.31
3.1
4.6
mmol/l
1.5
1.3
0.49
54
190
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
45
147
3.19
11.19
1.3
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
111
564
2.13
11.17
2.7
2.1
nmol/l
380.1
369.5
0.23
100
527
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
540
4425
1.76
11.04
5.1
3.0
u/l
47.2
47.7
0.06
513
4172
(3027801) Oxygen [Partial pressure] in Arterial blood
118
618
2.08
10.96
8.9
7.7
kpa
11.2
12.6
2.52
110
603
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
118
618
2.08
10.96
9.0
7.7
kpa
5.2
5.1
0.48
111
600
(3019069) Monocytes/100 leukocytes in Blood
392
2954
1.67
10.91
8.1
6.1
%
8.1
8.4
1.24
370
2772
(3043409) Potassium [Moles/volume] in Arterial blood
48
166
3.02
10.85
3.3
4.6
mmol/l
3.9
3.8
0.75
41
155
(3001122) Ferritin [Mass/volume] in Serum or Plasma
375
2799
1.67
10.79
3.6
2.6
ug/l
112.3
107.9
0.13
349
2612
(3018010) Neutrophils/100 leukocytes in Blood
395
2992
1.67
10.70
7.6
5.7
%
57.0
56.8
0.09
372
2809
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
133
737
1.98
10.54
2.8
2.3
%
20.3
23.1
1.25
110
646
(3019550) Sodium [Moles/volume] in Serum or Plasma
725
6612
3.04
10.52
25.8
13.6
mmol/l
139.2
139.7
4.34
713
6437
(3022217) INR in Platelet poor plasma by Coagulation assay
121
649
2.03
10.51
15.1
18.4
inr
1.2
1.2
0.05
21
86
(3002030) Lymphocytes/100 leukocytes in Blood
397
3033
1.65
10.23
7.8
5.9
%
28.9
28.4
0.36
371
2832
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
708
0.22
10.22
1.5
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
751
0.25
10.15
1.6
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
359
2679
1.64
10.12
2.5
2.2
nmol/l
74.0
76.6
0.87
328
2438
(3023103) Potassium [Moles/volume] in Serum or Plasma
725
6637
2.95
9.95
25.7
13.7
mmol/l
4.0
3.9
2.38
712
6448
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
16
8.25
9.76
2.8
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
16
8.25
9.76
2.8
2.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
39
128
3.16
9.64
2.3
4.1
umol/l
33.3
34.9
0.18
33
114
(3042936) Bacteria identified in Isolate by Culture
148
877
1.85
9.53
2.0
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
89
441
2.15
9.51
9.7
7.9
—
—
—
0
0
(3020891) Body temperature
53
210
2.64
9.33
6.1
4.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
236
1613
1.67
9.19
3.7
2.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
449
2.11
9.08
3.1
2.3
ug/l
4.5
7.8
2.04
82
403
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
668
5969
1.97
8.75
7.8
5.3
mmol/mol
41.1
39.3
4.09
636
5580
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
22
6.46
8.55
3.4
1.2
—
—
—
0
0
(3010421) pH of Blood
39
139
2.90
8.39
4.3
3.2
ph
7.4
7.4
1.76
28
116
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
325
2446
1.57
8.35
5.4
3.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
177
2569
0.59
8.29
3.5
2.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
364
2822
1.56
8.14
11.5
8.9
e9/l
0.0
0.0
0.24
306
2325
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
24
64
3.84
8.12
1.3
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
212
1451
1.64
8.04
4.9
3.4
—
—
—
0
0
(3044889) 12 lead EKG panel
528
4464
1.60
7.95
4.7
3.5
—
—
—
0
0
(4010399)
85
451
2.00
7.56
1.6
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
144
905
1.73
7.49
3.2
2.7
e6/l
6.5
2.8
1.49
85
468
(3009343) pH of Capillary blood
66
320
2.16
7.45
3.2
3.0
ph
7.5
7.4
—
7
52
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
64
307
2.18
7.42
3.1
3.1
mmol/l
2.2
2.0
0.20
46
231
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
101
573
1.88
7.37
3.1
2.3
u/l
28.6
36.7
1.47
87
484
(44816559) Phosphatidylethanol [Mass/volume] in Blood
34
123
2.85
7.15
1.2
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
97
550
1.88
7.09
4.2
2.7
%
1.9
1.8
0.53
85
496
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
478
0.22
7.04
1.2
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
34
125
2.80
6.95
1.7
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
54
252
2.23
6.71
4.1
3.3
mmol/l
24.0
24.2
0.19
46
224
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
698
6443
2.01
6.67
22.0
12.3
mg/l
20.8
21.8
0.38
600
5029
(3000570) Elastase.pancreatic [Mass/mass] in Stool
43
182
2.44
6.66
1.4
1.4
ug/g
443.3
306.1
0.49
29
102
(3017143) Hepatitis C virus Ab [Presence] in Serum
118
725
1.74
6.61
1.8
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
122
759
1.72
6.54
11.2
6.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
86
483
1.88
6.47
4.3
3.6
mmol/l
1.2
1.2
0.66
80
421
(3030981) Hyaline casts [#/volume] in Urine by Automated count
60
299
2.09
6.33
3.2
2.4
e6/l
0.8
0.2
0.94
60
290
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
149
987
1.63
6.29
3.0
2.5
e6/l
1.0
1.1
0.21
90
549
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
205
1472
1.54
6.12
1.8
1.7
mg/l
1.1
1.1
0.12
153
1118
(3015235) Bicarbonate [Moles/volume] in Capillary blood
34
135
2.59
6.02
2.0
2.2
mmol/l
25.4
25.0
0.20
29
125
(40761535) Cells panel - Urine sediment
85
487
1.84
6.01
5.7
3.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
28
101
2.84
5.95
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
32
4.44
5.78
2.4
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
14
32
4.44
5.78
1.1
1.4
nmol/l
139.1
159.4
0.51
14
32
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
684
6328
1.80
5.69
6.4
4.3
mmol/l
6.2
5.9
7.92
641
5833
(3047181) Lactate [Moles/volume] in Blood
37
159
2.39
5.58
11.1
7.4
mmol/l
1.3
1.3
0.09
31
144
(3023520) Reticulocytes [#/volume] in Blood
72
401
1.88
5.57
4.6
2.7
e9/l
79.0
72.0
0.85
54
294
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
107
672
1.69
5.52
3.5
2.8
umol/l
5.7
7.5
0.87
90
590
(3013139) Helicobacter pylori Ag [Presence] in Stool
77
440
1.83
5.50
1.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
67
366
1.91
5.50
1.5
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
45
213
2.18
5.44
2.2
1.5
mu/l
475.0
290.2
1.20
40
192
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
154
1067
1.56
5.33
5.5
3.5
ng/l
88.5
364.4
1.90
109
766
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
204
1502
1.49
5.31
1.4
1.3
u/ml
3.2
2.0
0.36
61
408
(3026389) Candida sp identified in Specimen by Organism specific culture
22
74
3.03
5.29
1.7
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
37
163
2.33
5.29
3.1
3.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
428
0.29
5.22
3.4
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
59
315
1.95
5.19
1.6
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
70
397
1.84
5.13
1.9
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
135
916
1.58
5.11
1.2
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
209
1559
1.47
5.07
4.7
3.6
%
95.3
94.8
0.10
200
1518
(3012501) Base excess in Blood by calculation
29
117
2.54
5.01
4.4
3.3
mmol/l
2.7
2.6
0.08
18
80
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
96
603
1.68
4.95
3.4
4.5
u/l
218.4
259.9
1.85
88
572
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
41
3.71
4.94
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
28
112
2.56
4.93
3.6
3.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
32
138
2.38
4.82
1.3
2.1
nmol/l
0.9
0.9
0.11
22
116
(3017509) Phencyclidine [Presence] in Urine
8
7
11.53
4.79
1.3
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
54
291
1.92
4.64
2.7
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
729
6947
2.17
4.63
14.8
9.9
u/l
26.4
26.2
0.11
710
6720
(3000034) Microalbumin [Mass/volume] in Urine
16
48
3.38
4.62
2.5
2.9
mg/l
16.4
15.7
0.04
11
31
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
56
307
1.89
4.57
1.8
1.6
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
11
25
4.45
4.57
2.0
3.0
umol/l
29.3
34.0
—
6
19
(3032080) INR in Blood by Coagulation assay
285
2287
1.39
4.53
8.3
7.5
inr
1.1
1.2
1.61
92
696
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
26
105
2.53
4.50
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
26
105
2.53
4.50
1.4
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
114
768
1.57
4.43
1.5
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
176
1301
1.46
4.41
1.4
1.4
g/l
2.2
2.4
0.59
106
819
(40760892) CBC W Ordered Manual Differential panel - Blood
197
1492
1.43
4.33
6.5
4.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
12
31
3.92
4.27
1.1
1.4
mmol/l
5.6
6.4
0.61
12
31
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
52
285
1.89
4.26
14.4
9.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
43
221
2.00
4.24
1.8
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
161
1180
1.46
4.20
2.0
1.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
69
415
1.73
4.18
2.4
3.5
pmol/l
4.1
4.6
3.98
55
370
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
64
377
1.76
4.17
2.2
2.9
ng/l
190.4
163.9
0.18
57
345
(3048689) Calprotectin [Mass/mass] in Stool
118
815
1.53
4.10
2.1
2.2
ug/g
107.6
125.6
0.34
93
647
(3044242) Glucose [Moles/volume] in Arterial blood
12
32
3.79
4.10
2.1
4.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
25
104
2.45
4.09
1.4
1.4
u/l
23.0
27.1
0.27
20
86
(3013512) EKG study
223
1747
1.39
4.00
5.0
3.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
23
93
2.52
4.00
1.3
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
86
561
1.60
3.84
2.2
2.2
g/l
0.2
0.2
0.48
79
532
(3017181) Myelocytes/100 leukocytes in Blood
81
521
1.62
3.83
5.6
4.2
%
1.0
0.8
0.24
25
148
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
73
458
1.66
3.80
4.1
3.4
ng/l
112.9
77.6
1.65
64
408
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
41
216
1.95
3.80
2.0
2.0
u/l
20013.1
2919.3
—
9
84
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
5
12.08
3.77
3.0
11.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
59
352
1.73
3.70
1.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
204
1596
1.38
3.65
2.6
2.5
umol/l
4406.6
5797.2
0.18
177
1406
(4062490)
16
56
2.90
3.64
1.1
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
81
528
1.60
3.63
2.3
2.5
ml/min/173m2
72.9
67.6
0.46
32
216
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
37
193
1.96
3.54
1.3
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
6
10.07
3.50
1.2
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
30
146
2.10
3.46
1.7
2.5
ug/min
63.0
102.2
0.47
15
89
(3020630) Protein [Mass/volume] in Serum or Plasma
69
438
1.63
3.45
2.3
2.9
g/l
65.3
67.5
1.36
63
406
(3014765) Yersinia sp identified in Stool by Organism specific culture
37
195
1.94
3.45
1.3
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
33
167
2.02
3.44
2.0
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
64
2.69
3.41
1.2
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
20
82
2.48
3.40
1.2
1.3
nmol/l
20.6
0.6
0.48
20
76
(3022313) Gas panel - Capillary blood
41
225
1.87
3.39
3.5
3.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
14
5.76
3.34
1.4
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
32
162
2.02
3.34
3.4
2.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
25
115
2.21
3.32
3.6
2.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
37
198
1.91
3.31
1.3
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
18
72
2.54
3.23
1.2
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
72
474
1.57
3.12
2.0
2.7
g/l
9.9
10.5
0.74
62
442
(40767503) Oxygen content in Capillary blood by calculation
24
113
2.16
3.03
3.6
2.2
%
16.3
16.5
0.08
12
60
(3036489) Thrombin time
40
227
1.80
3.01
1.5
2.0
s
23.1
21.5
0.25
32
199
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
29
148
2.00
2.98
1.2
1.5
e6/l
20.0
606.2
0.61
24
116
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
29
148
2.00
2.98
1.2
1.4
e6/l
6.8
5.9
0.07
23
111
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
76
2.40
2.91
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
105
761
1.44
2.89
2.1
2.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
39
223
1.79
2.87
2.1
2.1
g/l
1.6
1.5
0.25
33
196
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
23
109
2.14
2.87
2.0
1.3
u/ml
129.2
110.0
—
7
24
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
106
772
1.43
2.84
1.5
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
20
90
2.26
2.82
2.3
2.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
26
132
2.00
2.73
1.3
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
98
2.18
2.73
1.1
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
94
675
1.45
2.72
2.1
1.9
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
14
54
2.62
2.71
9.2
7.0
mmol/l
20.4
6.9
—
8
45
(3041096) Erythrocytes [Presence] in Urine by Automated
213
1747
1.30
2.69
4.6
3.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
72
492
1.51
2.67
6.1
4.3
%
0.1
0.1
0.08
23
133
(4034850)
35
201
1.78
2.56
20.4
8.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
27
144
1.91
2.49
4.1
4.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
27
144
1.91
2.49
1.4
1.7
e6/l
5849.6
11404.8
0.70
22
113
(3002385) Erythrocyte distribution width [Ratio]
584
5463
1.30
2.38
26.3
15.1
%
13.9
13.6
4.37
569
5348
(3025159) Blasts/100 leukocytes in Blood
67
463
1.49
2.37
6.1
4.4
%
0.0
0.9
0.62
17
115
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
52
2.53
2.37
1.1
1.0
—
—
—
0
0
(44813793)
13
52
2.53
2.37
1.2
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
705
6799
1.50
2.27
20.3
11.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
59
401
1.51
2.27
2.9
2.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
166
1.78
2.18
1.3
1.2
u/l
8.6
10.7
0.47
19
135
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
74
2.19
2.16
1.8
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
19
95
2.03
2.12
2.6
2.9
%
1.5
1.2
0.19
13
76
(3035637) Corticotropin [Mass/volume] in Plasma
15
68
2.23
2.12
1.3
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
46
302
1.56
2.08
11.4
8.9
mmol/l
24.3
24.4
0.07
39
287
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
15
4.02
2.04
1.0
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
22
118
1.89
2.03
2.0
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
120
1.86
1.94
2.0
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
11
4.57
1.94
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
687
6623
1.38
1.92
5.9
4.8
mmol/l
2.7
2.9
4.16
639
6170
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
157
0.38
1.90
1.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
136
1.79
1.89
2.0
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
22
3.20
1.88
2.4
2.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
66
478
1.42
1.88
5.0
4.1
%
0.6
0.4
0.40
15
105
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
206
1752
1.24
1.87
1.8
1.7
mmol/l
1.7
1.4
2.60
175
1492
(3024980) IgG subclass 4 [Mass/volume] in Serum
18
93
1.96
1.86
1.5
1.9
g/l
0.7
1.0
0.57
12
75
(3025130) Human papilloma virus identified in Specimen
17
86
2.00
1.86
1.8
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
43
288
1.52
1.81
1.5
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
49
694
0.69
1.80
1.4
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
54
381
1.45
1.77
1.5
1.6
g/l
1.2
1.4
0.61
48
357
(3035285) Chloride [Moles/volume] in Venous blood
14
67
2.11
1.77
2.4
2.4
mmol/l
105.2
105.8
0.12
14
67
(3041354) Potassium [Moles/volume] in Venous blood
14
67
2.11
1.77
2.4
2.4
mmol/l
4.0
4.0
0.03
14
67
(3017446) Testosterone [Moles/volume] in Serum or Plasma
53
373
1.45
1.76
2.6
2.2
nmol/l
10.8
12.9
1.08
44
344
(3009542) Hematocrit [Volume Fraction] of Blood
573
6017
0.81
1.76
24.0
13.0
%
38.3
40.0
3.18
349
4537
(3044640) Blood type and Crossmatch panel - Blood
230
1991
1.22
1.76
2.6
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
36
2.52
1.74
1.3
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
27
163
1.68
1.73
2.1
3.4
ratio
0.9
1.9
—
5
23
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
103
1.87
1.73
1.6
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
13
3.86
1.71
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
135
1.73
1.64
1.0
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
80
614
1.34
1.63
4.9
3.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
84
1.92
1.60
2.5
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
249
1.51
1.55
1.6
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
68
513
1.36
1.55
1.3
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
33
2.44
1.54
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
27
2.61
1.51
1.9
4.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
218
1.54
1.51
2.8
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
162
1.63
1.51
1.7
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
65
2.02
1.49
2.5
2.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
71
544
1.34
1.48
7.0
3.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
41
286
1.46
1.46
2.2
1.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
16
3.14
1.44
10.0
4.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
133
1.67
1.44
2.0
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
126
1.69
1.41
1.4
1.7
—
—
—
0
0
(3019225) pH of Specimen
74
576
1.32
1.39
5.1
3.7
—
—
—
0
0
(44790048)
13
67
1.96
1.39
2.7
1.6
—
—
—
0
0
(44806118)
13
67
1.96
1.39
2.7
1.6
—
—
—
0
0
(44790047)
13
67
1.96
1.39
2.7
1.6
—
—
—
0
0
(44790049)
13
67
1.96
1.39
2.7
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
673
6520
1.28
1.38
5.5
4.3
mmol/l
4.6
4.8
6.58
632
6107
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
112
1.71
1.36
1.4
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
17
2.95
1.36
1.4
4.1
%
58.6
54.6
—
5
17
(3024932) HLA-DR beta [Type]
5
17
2.95
1.36
1.2
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
318
0.62
1.32
1.2
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
98
1.75
1.32
2.4
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
119
991
1.24
1.31
1.8
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
218
0.54
1.30
1.1
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
18
2.79
1.28
2.6
2.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
116
0.43
1.26
1.2
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
25
2.41
1.24
1.8
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
25
2.41
1.24
1.8
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
36
2.23
1.24
1.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
49
2.05
1.22
2.0
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
49
2.05
1.22
1.0
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
49
2.05
1.22
2.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
49
2.05
1.22
2.0
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
330
3032
1.16
1.19
5.2
3.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
117
1.64
1.19
1.2
1.2
u/ml
221.9
260.3
—
10
69
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
157
1.55
1.18
1.2
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
94
1.72
1.18
1.4
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
199
1.48
1.16
3.0
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
36
258
1.41
1.15
1.2
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
20
2.51
1.15
1.4
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
163
1858
0.84
1.14
1.4
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
58
1.91
1.12
1.5
1.2
u/ml
0.3
0.3
—
6
21
(3004588) Protein electrophoresis panel - Serum or Plasma
50
381
1.33
1.12
2.0
2.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
280
0.63
1.11
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
120
1.60
1.09
3.9
3.3
e9/l
4.1
4.4
0.23
19
120
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
5
21
2.39
1.09
1.6
1.4
nmol/l
37.4
95.4
—
5
15
(3020650) Glucose [Presence] in Urine
5
21
2.39
1.09
2.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
41
1.96
1.09
2.0
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
30
211
1.44
1.07
3.9
3.4
g/l
0.5
0.2
0.72
13
80
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
33
2.13
1.05
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
33
2.13
1.05
1.1
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
48
368
1.32
1.04
1.5
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
64
511
1.28
1.04
1.1
1.2
iu/ml
100.7
145.3
0.63
19
207
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
646
6270
1.20
1.03
4.8
3.9
mmol/l
1.6
1.3
13.66
603
5823
(3035880) pH of Pleural fluid
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
48
1.89
1.00
2.9
2.1
—
—
—
0
0
(4024509)
9
48
1.89
1.00
1.1
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
65
800
0.79
1.00
2.8
2.7
ug/l
0.5
0.7
1.43
48
486
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
49
1.85
0.99
1.9
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
638
6192
1.19
0.98
18.3
11.2
ml/min/173m2
85.0
84.1
0.48
523
5053
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
27
190
1.44
0.98
1.8
2.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
100
1.61
0.97
1.1
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
1.1
—
193.9
—
0
31
(3023323) Follitropin [Units/volume] in Serum or Plasma
41
312
1.33
0.95
1.6
1.3
iu/l
23.8
30.8
0.73
36
264
(3024891) Influenza virus A+B Ag [Presence] in Specimen
24
166
1.46
0.95
1.3
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
28
200
1.42
0.94
1.5
2.0
%
98.5
92.2
0.69
22
186
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
125
1.53
0.94
4.3
3.6
%
54.8
57.8
0.39
19
125
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
125
1.53
0.94
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
20
290
0.68
0.91
1.3
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
19
127
1.51
0.89
3.5
3.7
mg/l
9.0
25.5
3.96
13
75
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
79
1.66
0.88
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
79
1.66
0.88
1.5
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
25
178
1.42
0.87
1.4
1.2
—
1542.9
—
0
7
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
26
187
1.40
0.86
1.8
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
145
1.46
0.85
3.1
2.9
u/ml
0.2
0.4
—
9
84
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
80
1.64
0.85
1.5
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
59
481
1.25
0.84
1.7
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
25
180
1.40
0.83
1.9
2.5
g/l
4.5
3.6
1.24
25
174
(3042631) Mycobacterium sp identified in Specimen
12
73
1.65
0.82
2.3
2.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
32
1.88
0.82
1.3
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
81
1.62
0.81
1.5
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
35
268
1.32
0.80
1.3
1.2
u/ml
0.3
1.7
—
7
18
(3034426) Prothrombin time (PT)
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
90
1.57
0.78
1.6
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
82
1.60
0.78
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
82
1.60
0.78
1.5
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
16
107
1.51
0.76
1.1
1.2
u/l
84.1
29.3
0.34
16
95
(3021788) Differential panel - Synovial fluid
16
107
1.51
0.76
1.4
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
59
1.70
0.76
1.7
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
37
289
1.29
0.75
3.4
3.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
116
1.48
0.74
4.1
2.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
54
1.67
0.74
1.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
24
2.09
0.74
1.2
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
134
0.59
0.74
1.3
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
55
1.64
0.73
1.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
26
1.93
0.70
1.6
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
5
26
1.93
0.70
1.2
1.1
g/l
0.3
0.3
—
5
19
(4306422)
14
93
1.51
0.70
1.1
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.4
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.4
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.4
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.4
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
168
1528
1.13
0.68
2.7
2.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
59
1.53
0.68
1.1
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
59
1.53
0.68
1.9
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
111
1.45
0.66
1.1
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
5
28
1.79
0.66
3.6
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
250
2674
0.90
0.65
2.2
2.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
120
1.43
0.65
1.4
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
18
129
1.40
0.64
2.3
3.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
175
0.68
0.61
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
175
0.68
0.61
1.3
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
88
1.49
0.61
1.8
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.3
—
0
10
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
174
0.68
0.59
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
174
0.68
0.59
1.3
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
53
1.51
0.58
2.6
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
53
1.51
0.58
3.3
3.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.1
—
57.0
—
0
5
(3037522) Nuclear Ab [Titer] in Serum
102
909
1.14
0.58
1.4
1.3
titre
363.1
572.7
0.88
13
202
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
662
6502
1.14
0.57
5.3
4.3
mmol/l
1.4
1.5
16.81
625
6064
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
81
1.49
0.57
2.4
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
240
0.74
0.56
2.6
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
55
1.46
0.56
2.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.55
1.8
1.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
37
1.63
0.55
3.0
2.9
%
97.7
101.5
—
6
37
(3051651) Icteric interference index of Serum or Plasma
6
37
1.63
0.55
3.5
3.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
147
1346
1.11
0.55
4.6
4.2
ug/l
1.7
1.9
0.25
132
1231
(3022145) Colonoscopy Study observation
85
752
1.15
0.54
1.5
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
38
1.58
0.54
1.2
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70
798
0.86
0.53
5.4
4.3
%
31.6
32.4
0.25
51
547
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
39
1.54
0.53
1.7
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
40
1.50
0.51
1.2
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
6
40
1.50
0.51
2.5
1.9
e6/l
697.7
481.9
—
6
34
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
64
1.41
0.51
4.0
2.1
pg
30.1
33.2
—
9
64
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
41
1.47
0.50
1.0
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
732
7255
1.24
0.49
34.0
18.3
e9/l
262.0
256.3
1.65
719
7085
(3002256) Pathology report gross observation
73
823
0.88
0.48
1.2
1.2
—
—
—
0
0
(4027681)
7
46
1.53
0.48
1.6
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
11
76
1.45
0.48
7.2
4.7
mg/l
11.4
11.7
0.08
11
69
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
133
1222
1.11
0.47
1.3
1.3
iu/ml
19.7
31.6
1.37
40
400
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
27
218
1.25
0.47
1.3
1.3
miu/ml
142.9
250.0
—
7
98
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
68
1.48
0.47
1.4
3.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
111
1.36
0.47
2.2
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
49
1.43
0.46
2.1
2.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
81
0.61
0.46
1.6
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
119
0.67
0.46
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
119
0.67
0.46
1.1
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
103
1.37
0.45
1.7
1.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
732
7259
1.22
0.45
33.9
18.2
fl
90.6
90.8
0.61
725
7161
(3035941) MCH [Entitic mass]
732
7259
1.22
0.45
33.9
18.2
pg
30.1
30.3
1.68
725
7161
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
451
4373
1.08
0.45
3.4
3.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
197
0.76
0.44
1.1
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
732
7260
1.22
0.44
34.0
18.3
e12/l
4.4
4.5
2.61
719
7076
(3023419) Bacteria identified in Sputum by Culture
11
78
1.42
0.43
2.1
3.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
732
7261
1.21
0.43
34.1
18.3
e9/l
7.0
6.6
7.90
719
7075
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
93
0.64
0.42
18.2
2.1
%
13.2
13.2
—
6
93
(1002224) Polysomnography panel
37
314
1.19
0.42
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.2
1.5
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
15
0.00
0.41
0.0
1.0
—
6.6
—
0
15
(3000963) Hemoglobin [Mass/volume] in Blood
732
7263
1.21
0.41
34.3
18.4
g/l
132.9
135.6
5.75
725
7166
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
195
1.24
0.41
1.9
2.0
g/l
3.0
3.1
0.39
17
161
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
186
1.24
0.40
1.3
1.9
iu/l
1.7
4.9
3.09
11
66
(3035933) Granulocytes/100 leukocytes in Blood
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
34
1.47
0.40
1.6
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
34
1.47
0.40
1.2
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
182
0.76
0.39
1.2
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
66
1.37
0.38
1.1
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
206
1.22
0.38
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
89
1.35
0.38
2.6
2.0
u/ml
6.1
49.0
0.48
12
84
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
115
0.69
0.37
1.3
1.1
—
12.5
—
0
10
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
70
1.29
0.36
1.3
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.2
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
109
1.29
0.33
1.8
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
47
1.28
0.32
1.2
1.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
92
1.31
0.32
2.5
2.4
—
913.1
—
0
7
(4035726)
51
565
0.90
0.29
1.5
1.4
—
—
—
0
0
(3000492) Spirometry study
60
658
0.90
0.29
1.6
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
15
184
0.81
0.29
1.1
1.2
—
2.7
—
0
21
(3014051) Protein [Presence] in Urine by Test strip
17
140
1.22
0.27
2.1
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
50
453
1.11
0.26
4.0
2.7
e9/l
4.1
4.1
0.01
39
366
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
8
67
1.20
0.26
2.4
4.9
—
59.7
—
0
23
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
43
477
0.90
0.26
2.4
2.4
—
14.8
—
0
26
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
207
1.16
0.25
1.9
2.0
g/l
7.3
7.4
0.09
17
168
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
207
1.16
0.25
1.9
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
207
1.16
0.25
1.9
2.0
g/l
3.8
3.8
0.11
17
157
(3023410) Appearance of Cerebral spinal fluid
9
74
1.22
0.25
1.8
1.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
23
198
1.17
0.25
1.6
1.6
g/l
0.2
0.2
0.32
23
188
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
24
208
1.16
0.24
1.6
1.6
g/l
1.2
1.2
0.11
24
196
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
38
1.32
0.23
2.8
1.9
e9/l
0.1
0.2
—
5
33
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
91
0.77
0.22
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
42
1.19
0.21
1.0
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
42
1.19
0.21
1.6
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.9
—
4.9
—
0
6
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
104
0.77
0.21
1.3
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
20
173
1.16
0.21
1.3
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
192
1.15
0.21
1.9
2.0
g/l
9.6
10.7
0.81
17
173
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
66
617
1.08
0.20
3.5
4.2
ug/l
22.3
14.9
0.21
56
492
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
144
0.83
0.20
1.3
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17
197
0.86
0.20
1.1
1.2
—
16.3
—
0
12
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
19
218
0.87
0.19
2.3
2.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
143
0.84
0.18
1.3
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
67
630
1.07
0.18
1.7
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
62
1.13
0.17
1.4
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
11
92
1.20
0.16
1.2
1.3
—
62.8
—
0
6
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
80
0.75
0.15
1.2
1.3
ug/l
1.3
2.9
—
6
69
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
133
1285
1.04
0.15
1.8
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
149
0.87
0.13
1.2
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
180
0.89
0.13
1.2
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
112
1085
1.04
0.11
4.0
3.8
%
23.3
21.2
0.55
45
463
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
86
1.16
0.11
1.7
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
45
1.11
0.10
2.6
1.9
—
49.7
—
0
6
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
57
1.05
0.08
2.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
107
1.12
0.08
1.4
1.1
—
—
—
0
0
(4146454)
5
60
0.83
0.08
2.0
2.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
64
0.78
0.08
1.2
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
66
1.06
0.08
1.1
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
68
1.03
0.08
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
564
5610
1.02
0.07
31.2
15.8
g/l
331.5
332.3
1.62
559
5573
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
20
186
1.08
0.07
2.5
2.3
mg/l
11.7
11.8
0.03
20
173
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
78
1.03
0.07
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
81
0.86
0.07
1.0
1.1
—
—
—
0
0
(4281824)
9
86
1.05
0.07
1.0
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
14
152
0.92
0.06
1.1
1.2
—
46.7
—
0
15
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
128
1301
0.98
0.05
1.5
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
120
1181
1.02
0.05
1.3
1.3
u/ml
8.6
11.1
0.17
45
476
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
18
170
1.06
0.04
2.6
3.2
mg/l
1.9
1.6
0.46
18
160
(3037756) Immunofixation for Serum or Plasma
11
119
0.92
0.04
1.1
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
102
1.08
0.03
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
188
0.96
0.02
1.6
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
106
0.94
0.01
1.3
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
146
0.96
0.00
1.1
1.2
—
1.1
—
0
10
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
118
1.02
0.00
1.3
1.1
u/ml
1.6
2.7
—
7
44
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
32.8
—
0
8
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
76
0.92
0.00
1.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
75
0.93
0.00
2.3
2.6
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
52
0.96
0.00
1.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
52
0.96
0.00
1.0
1.2
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
77
0.91
0.00
1.1
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
2.5
—
0
5
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
330.6
—
0
5
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
69
1.01
0.00
1.3
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
73
0.96
0.00
1.6
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
52
0.96
0.00
1.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
65
0.92
0.00
2.5
2.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
65
0.92
0.00
1.3
1.3
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4094501)
18
180
1.00
0.00
1.1
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
3.4
—
7.6
—
0
5
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
6
66
0.91
0.00
2.5
2.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
56
0.89
0.00
4.2
4.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_DEPPER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_DEPPER | 2.607 [2.27, 2.99] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.36 |
During the follow-up period (1.1.1998 — 31.12.2019), 342 out of 2422 females with F5_DEPPER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_DEPPER | 2.902 [2.43, 3.46] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 189 out of 886 males with F5_DEPPER died.
Mortality risk
Mortality risk for people of age
years, who have F5_DEPPER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.306% | 0.537% |
| 5 | 1.551% | 3.18% |
| 10 | 3.661% | 8.005% |
| 15 | 7.12% | 14.384% |
| 20 | 12.488% | 24.068% |
Relationships between endpoints
↥Index endpoint: F5_DEPPER – Dependent personality disorder
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data